Insider filing · HQL
Saba Capital Management, L.P. sold $612K of abrdn Life Sciences Investors (HQL)
Executed Mar 31 2025, disclosed Apr 1 2025, 1 day later.
Value, as filed
$612K
48,623 sh × $12.58
Executed
Mar 31 2025
the trade date, as filed
Disclosed
Apr 1 2025
1 day after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
SP
Saba Capital Management, L.P.
10% owner
profile →
Saba Capital Management, L.P. (10% owner) filed 334 Form 4 reports as a reporting entity in the trailing twelve months (142 purchases, 192 sales, 5 filed past the two-business-day deadline), most often in BlackRock ESG Capital Allocation Term Trust (ECAT). Across 140 priced purchase filings, the average 21-session return was +5.2% from execution and +5.2% from disclosure (delay-adjusted; derived). The largest single filing was $9.4M of ASA (134,093 sh across 2 lots, as filed), executed Feb 12.
The name
HQL
HQL
HQL · 21 filings in 24 months
ticker →
Insider filings, newest first→
View the original filing at www.sec.gov→
Other filings by Saba Capital Management, L.P. in HQL
HQLSALE
abrdn Life Sciences Investors
$589K41,623 sh × $14.14
Exec Sep 22 2025
Filed Sep 23 2025 · 5:30 PM ET HQLSALE abrdn Life Sciences Investors $906K
64,536 sh across 2 lots
Exec Sep 17 2025
Filed Sep 19 2025 · 5:30 PM ET HQLSALE abrdn Life Sciences Investors $216K
15,116 sh × $14.28
Exec Sep 11 2025
Filed Sep 15 2025 · 5:30 PM ET HQLSALE abrdn Life Sciences Investors $151K
10,710 sh × $14.07
Exec Aug 21 2025
Filed Aug 25 2025 · 5:30 PM ET HQLSALE abrdn Life Sciences Investors $152K
12,689 sh × $11.98
Exec May 8 2025
Filed May 12 2025 · 5:30 PM ET HQLSALE abrdn Life Sciences Investors $180K
15,400 sh × $11.67
Exec Apr 14 2025
Filed Apr 15 2025 · 5:30 PM ET HQLSALE abrdn Life Sciences Investors $336K
30,156 sh × $11.14
Exec Apr 10 2025
Filed Apr 14 2025 · 5:30 PM ET HQLSALE abrdn Life Sciences Investors $428K
32,922 sh × $13.01
Exec Mar 27 2025
Filed Mar 31 2025 · 5:30 PM ET